Pharmacological manipulation of human gastrointestinal blood flow.
The splanchnic circulation is one of the largest vascular regions in man. In the past, this has been difficult to study because of methodological problems. The adapting of noninvasive Doppler techniques has made it possible to develop reproducible measurements of coeliac and superior mesenteric artery blood flow, which are the main contributors to the gastrointestinal vasculature. This has resulted in the further understanding of neurogenic and humoral control of this region in a number of physiological and pathophysiological states, and has contributed towards the knowledge of its pharmacological control. These studies are of relevance to cardiovascular homeostasis and, in particular, systemic blood pressure control which depends upon various factors including responses in different vascular regions. In this review the key physiological factors which influence pharmacological studies on this circulation will be discussed. Examples will be provided, in subjects with cardiovascular and neurological disorders, of how administration of endogenous and exogenous substances, including drugs with specific pharmacological effects, alter human gastrointestinal blood flow. These will include insulin, alcohol, the somatostatin analogue octreotide, the central acting sympatholytic clonidine and the angiotensin II-converting inhibitor captopril. The relevance of these studies to subjects with postural hypotension due to sympathetic denervation and to primary hypertension, in particular, will be discussed.
Mathias
C J
CJ
Department of Medicine, St Mary's Hospital/Imperial College School of Medicine, London, UK.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D001342:Autonomic Nervous System Diseases / Q000503:physiopathology; D002216:Captopril / Q000494:pharmacology; D003000:Clonidine / Q000494:pharmacology; D004064:Digestive System / Q000098:blood supply*; D000431:Ethanol / Q000494:pharmacology; D005765:Gastrointestinal Agents / Q000494:pharmacology; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D017538:Mesenteric Artery, Superior / Q000187:drug effects* / Q000502:physiology; D015282:Octreotide / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects / Q000502:physiology; D013152:Splanchnic Circulation / Q000187:drug effects* / Q000502:physiology
D000316:Adrenergic alpha-Agonists; D000959:Antihypertensive Agents; D005765:Gastrointestinal Agents; D007328:Insulin; D000431:Ethanol; D002216:Captopril; D003000:Clonidine; D015282:Octreotide